Reprocessed Medical Devices Market Size, Share, Opportunities, And Trends By Product (Cardiovascular, Laparoscopic, Gastroenterology, General Surgery Devices, Others), By Type (Third-party Reprocessing, In-house Reprocessing), By End-User (Hospitals, Clinics, Others), And By Geography - Forecasts From 2023 To 2028

  • Published : Aug 2023
  • Report Code : KSI061615902
  • Pages : 141

The reprocessed medical devices market is expected to grow at a CAGR of 9.73% from US$13.92 billion in 2021 to US$26.661 billion in 2028.

Reprocessed medical devices refer to medical devices that have undergone a thorough cleaning, testing, and refurbishment process to be used again for medical purposes. These devices are typically single-use items that are intended for use on a single patient and then discarded. Various advantages of reprocessing along with the growing demand for healthcare services owing to the growing population are expected to bolster the reprocessed medical devices market. Moreover, the rising cases of cardiovascular diseases coupled with technological advances and institutional support are further contemplated to augment the reprocessed medical devices market.

Advantages of Reprocessed Medical Devices

One of the primary drivers for the reprocessed medical devices market is cost reduction. Reprocessing allows healthcare facilities to access medical devices at a lower cost compared to purchasing new ones. According to the Association of Medical Devices Reprocessors (AMDR, US), reprocessed medical devices can reduce the cost by an average of 30-50%. Moreover, reprocessing allows for the extended use of certain medical devices beyond their original single-use purpose. This extends the life cycle of the devices, making them a more efficient and economical option for healthcare providers. These factors are expected to augment the reprocessed medical devices market.

Growing Demand for Healthcare Services

The increasing global demand for healthcare services coupled with budget constraints in many healthcare systems has led to a greater focus on cost-efficient strategies which are accelerating the reprocessed medical devices market. Reprocessed medical devices offer a way for healthcare providers to optimize their resources without compromising patient care. For instance, the U.S. Bureau of Labor Statistics estimates that employment in healthcare is projected to increase by 13% between 2021 and 2031 owing to the growing population and their associated health concerns. For example, the world population is estimated to cross the 8.5 billion mark by 2030 according to the United Nations estimations.

Increasing Demand for Cardiovascular Devices

Cardiovascular diseases (CVDs) remain a significant global health concern leading to more demand for cardiovascular devices. Therefore, the increasing cases of CVD are expected to accelerate the reprocessed medical devices market. For instance, cardiovascular illnesses which caused 20.5 million deaths in 2021, continue to impact more than half a billion people worldwide according to the World Heart Federation. Moreover, higher blood pressure accounted for around 10.8 million deaths of total CVD death as per the same source. Premature heart attacks and strokes can be avoided in up to 80% of cases through devices and developed medicines.

Government and Institutional Support

Many healthcare providers have embraced the use of reprocessed medical devices as part of their cost-containment strategies which is expected to aid the reprocessed medical devices market. The Mayo Clinic has put in place recycling programs for many different products, including medical gadgets. The Mayo Clinic effectively diverts more than 22,000 pounds of trash annually from landfills by recycling surgical products and devices. Moreover, In addition to saving $544,662 on medical equipment expenditures, Innovative Health Inc. said that hospitals that took advantage of its yearly sustainability program lowered carbon emissions by an average of 7,219 pounds in 2022.

 Advances in Reprocessed Technology

The development of advanced reprocessing technologies has further boosted the reprocessed medical devices market. Improved cleaning, testing, and sterilization techniques ensure that reprocessed devices meet the same safety and efficacy standards as new devices, making them a viable option for healthcare facilities. For example, the safe recycling of catheters and several other medical devices is made possible by a recently created Catheter recycling System (CRS). It assures the safety of doctors and patients while reprocessing medical devices with little human involvement.

Restraints in the Market

The reprocessed medical devices market has experienced growth and development however some restraints or challenges can impact its expansion. For example, Obtaining regulatory approval for reprocessed devices can be a complex and time-consuming process, and not all devices may meet the necessary criteria for reprocessing. Some medical devices are intricate in design and may contain multiple components, which can make the reprocessing process more challenging and time-consuming. Additionally, certain materials used in medical devices may not be suitable for reprocessing, limiting the range of devices that can be reprocessed safely.

North America is Expected to Grow Significantly

North America is expected to hold a significant share of the reprocessed medical devices market during the forecast period. The factors attributed to such a share are the increasing burden of cardiovascular disease, advanced healthcare facilities, the growing elderly population, and government support. For instance, around 695,000 US people died from heart disease in the year 2021 according to the CDC which means one person died every 33 seconds in the US from CVDs. Moreover, the presence of major reprocessing companies such as J&J Medtech, Steris Corporation, and Nelson Labs further bolsters the reprocessed medical devices market.

Major Market Players

  • Johnson & Johnson (J&J) Medtech is a prominent and well-known multinational healthcare company with a diverse portfolio of products, including medical devices. It sells single-use devices that have been reprocessed and made by Sterilmed, Inc.  (a subsidiary of the Johnson & Johnson Family of Companies). It also processes devices made by other OEMs.
  • Steris Corporation is a leading global provider of infection prevention, decontamination, and surgical and critical care products and services. It provides endoscopy reprocessing through its products such as Verify® Resi-Test Cleaning Indicators, SPM® Endo Workflow Solution, and others.
  • Nelson Labs offers a wide range of services to help companies ensure the safety, quality, and compliance of their products. The clinical reprocessing services offered by the company offer a Flexible Endoscope Sampling Kit, sterilization validation, functionality testing, and disinfection validation.

Key Market Developments

  • In November 2022, Cardinal Health opened its expanded Sustainable Technologies facility in Florida. It is now twice as large as before which will enable the business to bring new products for customers and better meet increasing demand for existing products through reprocessing.
  • In May 2022, Innovative Health, LLC obtained clearance to reprocess the Philips Eagle Eye Platinum digital IVUS catheter, which is predominantly utilized in cath labs for interventional cardiology procedures. This marked Innovative Health's initial approval for reprocessing a non-electrophysiology catheter.

Segmentation:

  • By Product
    • Cardiovascular
    • Laparoscopic
    • Gastroenterology
    • General Surgery Devices
    • Others
  • By Type
    • Third-party Reprocessing
    • In-house Reprocessing
  • By End-User
    • Hospitals
    • Clinics
    • Others
  • By Geography
    • North America
      • United States
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • United Kingdom
      • Germany
      • France
      • Spain
      • Others
    • Middle East and Africa
      • Saudi Arabia
      • UAE
      • Israel
      • Others
    • Asia Pacific
      • Japan
      • China
      • India
      • South Korea
      • Indonesia
      • Thailand
      • Others

1.  INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY  

2.1. Research Data

2.2. Assumptions

3. EXECUTIVE SUMMARY

3.1. Research Highlights

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Force Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

5. REPROCESSED MEDICAL DEVICES MARKET, BY PRODUCT

5.1. Introduction

5.2. Cardiovascular

5.3. Laparoscopic

5.4. Gastroenterology

5.5. General Surgery Devices

5.6. Others

6. REPROCESSED MEDICAL DEVICES MARKET, BY TYPE

6.1. Introduction

6.2. Third-party Reprocessing

6.3. In-house Reprocessing

7. REPROCESSED MEDICAL DEVICES MARKET, BY END-USER

7.1. Introduction

7.2. Hospitals

7.3. Clinics

7.4. Others

8. REPROCESSED MEDICAL DEVICES MARKET, BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. United States

8.2.2. Canada

8.2.3. Mexico

8.3. South America

8.3.1. Brazil

8.3.2. Argentina

8.3.3. Others

8.4. Europe

8.4.1. United Kingdom

8.4.2. Germany

8.4.3. France

8.4.4. Spain

8.4.5. Others

8.5. The Middle East and Africa

8.5.1. Saudi Arabia

8.5.2. UAE

8.5.3. Israel

8.5.4. Others

8.6. Asia Pacific

8.6.1. Japan

8.6.2. China

8.6.3. India

8.6.4. South Korea

8.6.5. Indonesia

8.6.6. Thailand

8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Vendor Competitiveness Matrix

10. COMPANY PROFILES

10.1. 3M

10.2. J&J Medtech

10.3. Steris

10.4. Tuttnauer

10.5. Nelson Labs

10.6. Arjo

10.7. Alberta Health Services

10.8. Cardinal Health

10.9. NE Scientific


3M

J&J Medtech

Steris

Tuttnauer

Nelson Labs

Arjo

Alberta Health Services

Cardinal Health

 

NE Scientific